Literature DB >> 20595600

FDA regulations for drug development.

Rachel E Behrman, Janet Woodcock.   

Abstract

Mesh：

Year:  2010        PMID： 20595600     DOI： 10.1126/science.329.5987.33-b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  3 in total

1.  High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.

Authors:  Samuel A Siles; Anand Srinivasan; Christopher G Pierce; José L Lopez-Ribot; Anand K Ramasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

2.  Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans.

Authors:  Kevin Kim; Leeor Zilbermintz; Mikhail Martchenko
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-06-09       Impact factor: 3.944

3.  Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.

Authors:  Hongbo Shen; Feifei Wang; Gucheng Zeng; Ling Shen; Han Cheng; Dan Huang; Richard Wang; Lijun Rong; Zheng W Chen
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.